AS
Abhai Sachidanand Attavar
About Abhai Sachidanand Attavar
Data last updated:
Abhai Sachidanand Attavar is a Director at Dana Pharmaceuticals Private Limited (since 2022) and Director at Dana Overseas Private Limited (since 2022). The companies operate in Pharma and Machinery and Equipment. The 2 current companies with reported revenue have a combined latest revenue of ₹1.96 Cr; the largest is Dana Pharmaceuticals Private Limited at ₹1.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Aug 2022 | 1996 | ₹1.96 Cr (FY 2025) | Active | |
| Director | 02 Aug 2022 | 1996 | ₹13,020 (FY 2022) | Active |
Board colleagues of Abhai Sachidanand Attavar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gautam Hathiramani Ramesh | 01744235 | Dana Pharmaceuticals Private Limited , Dana Overseas Private Limited | Director |
| Jacky Ramesh Hathiramani | 01761971 | Dana Pharmaceuticals Private Limited , Dana Overseas Private Limited | Director |
| Suresh Sagarmal Parmar | 09692566 | Dana Pharmaceuticals Private Limited , Dana Overseas Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhai Sachidanand Attavar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhai Sachidanand Attavar
Abhai Sachidanand Attavar currently holds 2 directorships: Dana Pharmaceuticals Private Limited (Director, since 02 Aug 2022, revenue ₹1.96 Cr (FY 2025)); Dana Overseas Private Limited (Director, since 02 Aug 2022, revenue ₹13,020 (FY 2022)).
Abhai Sachidanand Attavar was first appointed on 02 Aug 2022 as Director at Dana Pharmaceuticals Private Limited.
The 2 current companies of Abhai Sachidanand Attavar that report revenue have a combined latest revenue of ₹1.96 Cr: Dana Pharmaceuticals Private Limited ₹1.96 Cr (FY 2025); Dana Overseas Private Limited ₹13,020 (FY 2022).
The current boards of Abhai Sachidanand Attavar's companies include Gautam Hathiramani Ramesh (Dana Pharmaceuticals Private Limited), Jacky Ramesh Hathiramani (Dana Pharmaceuticals Private Limited), Suresh Sagarmal Parmar (Dana Pharmaceuticals Private Limited).